Literature DB >> 18651248

Influence of PACAP on oxidative stress and tissue injury following small-bowel autotransplantation.

Andrea Ferencz1, Boglarka Racz, Andrea Tamas, Dora Reglodi, Andrea Lubics, Jozsef Nemeth, Klara Nedvig, Karoly Kalmar-Nagy, Ors Peter Horvath, Gyorgy Weber, Erzsebet Roth.   

Abstract

Tissue injury caused by cold preservation and reperfusion remains an unsolved problem during small-bowel transplantation. Pituitary adenylate cyclase-activating polypeptide (PACAP) is present and plays a central role in the intestinal physiology. This study investigated effect of PACAP-38 on the oxidative stress and tissue damage in autotransplanted intestine. Sham-operated, ischemia/reperfusion, and autotransplanted groups were established in Wistar rats. In ischemia/reperfusion groups, 1 h (group A), 2 h (group B), and 3 h (group C) ischemia followed by 3 h of reperfusion was applied. In autotransplanted groups, total orthotopic intestinal autotransplantation was performed. Grafts were preserved in University of Wisconsin (UW) solution and in UW containing 30 microg PACAP-38 for 1, 2, 3, and 6 h. Reperfusion lasted 3 h in all groups. Endogenous PACAP-38 concentration was measured by radioimmunoassay. To determine oxidative stress parameters, malondialdehyde, reduced glutathione, and superoxide dismutase were measured in tissue samples. Tissue damage was analyzed by qualitative and quantitative methods on hematoxylin/eosin-stained sections. Concentration of endogenous PACAP-38 significantly decreased in groups B and C compared to sham-operated group. Preservation solution containing PACAP-38 ameliorated bowel tissue oxidative injury induced by cold ischemia and reperfusion. Histological results showed that preservation caused destruction of the mucous, submucous, and muscular layers, which were further deteriorated by the end of reperfusion. In contrast, PACAP-38 significantly protected the intestinal structure. Ischemia/reperfusion decreased the endogenous PACAP-38 concentration in the intestinal tissue. Administration of PACAP-38 mitigated the oxidative injury and histological lesions in small-bowel autotransplantation model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651248     DOI: 10.1007/s12031-008-9132-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  51 in total

Review 1.  Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP.

Authors:  Catalina Abad; Rosa P Gomariz; James A Waschek
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

2.  Control of oxidative stress in small bowel: relevance to organ preservation.

Authors:  Payam Salehi; John Walker; Karen Madsen; Thomas A Churchill
Journal:  Surgery       Date:  2006-03       Impact factor: 3.982

3.  Goals of small bowel preservation.

Authors:  A R Mueller; K P Platz; P Neuhaus; K K Lee; W H Schraut
Journal:  Transplant Proc       Date:  1996-10       Impact factor: 1.066

4.  Characterization of intestinal receptors for VIP and PACAP in rat and in PAC1 receptor knockout mouse.

Authors:  E Ekblad; H Jongsma; P Brabet; J Bockaert; F Sundler
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

5.  Distribution of PACAP-38 in the central nervous system of various species determined by a novel radioimmunoassay.

Authors:  Balázs Jakab; Dóra Reglodi; Rita Józsa; Tibor Hollósy; Andrea Tamás; Andrea Lubics; István Lengvári; Gábor Oroszi; Zoltán Szilvássy; János Szolcsányi; József Németh
Journal:  J Biochem Biophys Methods       Date:  2004-10-29

6.  Intestinal ischemic preconditioning in rats and NF-kappaB activation.

Authors:  Andrea Ferencz; Boglarka Racz; Balazs Gasz; Laszlo Benko; Gabor Jancso; Maria Kurthy; Erzsbet Roth
Journal:  Microsurgery       Date:  2006       Impact factor: 2.425

7.  Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals.

Authors:  Dóra Reglodi; Zsolt Fábián; Andrea Tamás; Andrea Lubics; József Szeberényi; Tamás Alexy; Kálmán Tóth; Zsolt Márton; Balázs Borsiczky; Erzsébet Rõth; Luca Szalontay; István Lengvári
Journal:  Regul Pept       Date:  2004-12-15

8.  Alleviating ischemia-reperfusion injury in small bowel.

Authors:  Payam Salehi; Karen Madsen; Jay Zhu; Erika Castillo; Jose Avila; Jonathan R T Lakey; Thomas A Churchill
Journal:  Am J Transplant       Date:  2004-05       Impact factor: 8.086

9.  Pituitary adenylate cyclase-activating peptide (PACAP), a VIP-like peptide, has prolonged airway smooth muscle relaxant activity.

Authors:  H D Foda; H H Sharaf; A Absood; S I Said
Journal:  Peptides       Date:  1995       Impact factor: 3.750

10.  PACAP protects hippocampal neurons against apoptosis: involvement of JNK/SAPK signaling pathway.

Authors:  S Shioda; H Ozawa; K Dohi; H Mizushima; K Matsumoto; S Nakajo; A Takaki; C J Zhou; Y Nakai; A Arimura
Journal:  Ann N Y Acad Sci       Date:  1998-12-11       Impact factor: 5.691

View more
  12 in total

1.  Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells.

Authors:  Gabriella Horvath; Reka Brubel; Krisztina Kovacs; Dora Reglodi; Balazs Opper; Andrea Ferencz; Peter Szakaly; Eszter Laszlo; Lidia Hau; Peter Kiss; Andrea Tamas; Boglarka Racz
Journal:  J Mol Neurosci       Date:  2010-07-30       Impact factor: 3.444

2.  Comparison of intestinal warm ischemic injury in PACAP knockout and wild-type mice.

Authors:  Andrea Ferencz; Peter Kiss; Gyorgy Weber; Zsuzsanna Helyes; Norihito Shintani; Akemichi Baba; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2010-04-13       Impact factor: 3.444

3.  Pituitary Adenylate Cyclase-activating Polypeptides Prevent Hepatocyte Damage by Promoting Yes-associated Protein in Liver Ischemia-Reperfusion Injury.

Authors:  Yuan Liu; Tianfei Lu; Cheng Zhang; Zhengze Xue; Jin Xu; Ronald W Busuttil; Qiang Xia; Ning Xu; Jerzy W Kupiec-Weglinski; Haofeng Ji
Journal:  Transplantation       Date:  2019-08       Impact factor: 4.939

4.  Presence of endogenous PACAP-38 ameliorated intestinal cold preservation tissue injury.

Authors:  Andrea Ferencz; Gyorgy Weber; Zsuzsanna Helyes; Hitoshi Hashimoto; Akemichi Baba; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2010-04-09       Impact factor: 3.444

5.  Changes of PACAP immunoreactivities and cytokine levels after PACAP-38 containing intestinal preservation and autotransplantation.

Authors:  Klara Nedvig; Gyorgy Weber; Jozsef Nemeth; Krisztina Kovacs; Dora Reglodi; Agnes Kemeny; Andrea Ferencz
Journal:  J Mol Neurosci       Date:  2012-08-17       Impact factor: 3.444

6.  Effects of PACAP on mitochondrial apoptotic pathways and cytokine expression in rats subjected to renal ischemia/reperfusion.

Authors:  Gabriella Horvath; Boglarka Racz; Dora Reglodi; Krisztina Kovacs; Peter Kiss; Ferenc Gallyas; Zita Bognar; Aliz Szabo; Tamas Magyarlaki; Eszter Laszlo; Andrea Lubics; Andrea Tamas; Gabor Toth; Peter Szakaly
Journal:  J Mol Neurosci       Date:  2010-03-16       Impact factor: 3.444

7.  PACAP is an endogenous protective factor-insights from PACAP-deficient mice.

Authors:  D Reglodi; P Kiss; K Szabadfi; T Atlasz; R Gabriel; G Horvath; P Szakaly; B Sandor; A Lubics; E Laszlo; J Farkas; A Matkovits; R Brubel; H Hashimoto; A Ferencz; A Vincze; Z Helyes; L Welke; A Lakatos; A Tamas
Journal:  J Mol Neurosci       Date:  2012-04-14       Impact factor: 3.444

Review 8.  PACAP deficiency as a model of aging.

Authors:  D Reglodi; T Atlasz; E Szabo; A Jungling; A Tamas; T Juhasz; B D Fulop; A Bardosi
Journal:  Geroscience       Date:  2018-10-22       Impact factor: 7.713

Review 9.  Protective effects of PACAP in ischemia.

Authors:  Dora Reglodi; Alexandra Vaczy; Eloísa Rubio-Beltran; Antoinette MaassenVanDenBrink
Journal:  J Headache Pain       Date:  2018-03-02       Impact factor: 7.277

Review 10.  Protective Effects of PACAP in Peripheral Organs.

Authors:  Denes Toth; Edina Szabo; Andrea Tamas; Tamas Juhasz; Gabriella Horvath; Eszter Fabian; Balazs Opper; Dora Szabo; Grazia Maugeri; Agata G D'Amico; Velia D'Agata; Viktoria Vicena; Dora Reglodi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-14       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.